MRI Can Predict Progression to Multiple Sclerosis from Clinically Isolated Syndrome
August 16th 2018Certain magnetic resonance imaging (MRI) parameters correlated with a greater risk of recurrence and progression to multiple sclerosis within the first year following diagnosis of clinically isolated syndrome.
Read More
BTK Inhibitor Shows Potential in Early Phase Trial for MS
August 15th 2018A phase 1 trial evaluating the safety and tolerability of PRN2246, a Bruton's tyrosine kinase (BTK) inhibitor, found the drug having no serious medication-related adverse events in healthy volunteers while also being able to reach the brain.
Read More